Protagonist Therapeutics, Inc. (PTGX)
87.25
-0.68
(-0.77%)
USD |
NASDAQ |
Dec 30, 16:00
87.25
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics EPS Diluted (Quarterly): -0.6169 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| ADMA Biologics, Inc. | 0.1489 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Bristol Myers Squibb Co. | 1.079 |
| MannKind Corp. | 0.0256 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.34M |
| Revenue (Quarterly) | 4.712M |
| Total Expenses (Quarterly) | 44.05M |
| Enterprise Value | 4.932B |
| Gross Profit Margin (Quarterly) | 92.34% |
| Profit Margin (Quarterly) | -834.9% |
| Earnings Yield | 0.73% |
| Operating Earnings Yield | 0.34% |
| Normalized Earnings Yield | 0.7258 |